Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | N/A | AK334 | IM / RA |
APRN alerted nursing staff through Teams Chat to give a TDAP vaccine to a patient . I did not see the message when it was sent, and 10 minutes later provider came to the lab where nurses work and asked if we had seen the message and the patient had been waiting. I prepared the vaccine, scanned the vaccine in the patient's chart and went to the patient room I believed I was supposed to go to. I was rushing a bit because I knew the patient had been waiting. In the room I asked the patient his first name starting with the same letter and he confirmed. Unfortunately, I did not ask any other identifiers, as I was concerned he had been waiting for a while. I explained to the patient that he would be getting a TDAP and proceeded to ask the following standard questions we ask prior to giving any vaccine, He said no to all of these. He agreed to take the vaccine and asked if it could be administered in the right arm. I then gave the vaccine, and afterwards he asked if he was still going to see the provider. At that moment I realized that this was not the patient the provider wanted me to give the vaccine to, as he always asks for vaccines after he has seen the patient. I asked the patient to repeat his name, and he said initials. I asked why he confirmed his name started with a different letter and he said he was distracted with his phone. I had to explain to the patient what happened. He asked if there was any danger getting the TDAP if he did not need it at this time. I looked in his chart and saw he had a TDAP in 2023. I told him this would not be detrimental to his health, but apologized for the incident and told him I would report this to his provider, my managers and take all the proper channels to report what happened. The patient was very nice about it, and said he understood it was a mistake but he was not going to pursue any actions. I reported the incident to my supervisor and she contacted our regional manager for the next step which was to report the incident to VAERS as well as our own company adverse event reporting system.
None
ENT Deviated septum Gastroenterology and Abdominal Diverticulosis GERD (gastroesophageal reflux disease) Genitourinary and Reproductive Erectile dysfunction Infectious Disease Genital herpes Encounter for immunization STD exposure Screening for STDs (sexually transmitted diseases) Mental Health Generalized anxiety disorder with panic attacks Posttraumatic stress disorder Major depression Musculoskeletal and Injuries Left knee pain Neurology/Nerve HaNDL (headache, transient neurologic deficits and CSF lymphocytosis) Tourette syndrome Migraine Sleep Chronic insomnia Social High risk sexual behavior, unspecified type
ALPRAZolam (Tab) ALPRAZolam 1 MG take 1 tab po qd as needed Aspirin-Acetaminophen-Caffeine (Tab) Excedrin Extra Strength 250-250-65 MG TAKE 1 TABLET PRN clonazePAM (Tab) clonazePAM 2 MG Take 1 tablet twice daily clonazePAM (Tab) clonaze
Quetiapine
Not needed